# Impact of Diffuse Myocardial Fibrosis on the Ventricular Function in Regurgitant Left-Sided Valve Heart Diseases ( The DIFFUsE Study)

Study · id `cardio:ct-nct02747485` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02747485](<https://clinicaltrials.gov/study/NCT02747485>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02747485

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 316 participants.

## Technical summary

Registry record NCT02747485. Allocation not applicable; no masking; primary purpose prevention. Start 2016-05 (actual); primary completion 2026-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 316 participants (planned count; ClinicalTrials.gov record NCT02747485, source copy `cardio:ctgov-nct02747485-2026-05-19`, retrieved 2026-10-26)
- Started: 2016-05 (actual) (ClinicalTrials.gov record NCT02747485, source copy `cardio:ctgov-nct02747485-2026-05-19`, retrieved 2026-10-26)
- Primary completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT02747485, source copy `cardio:ctgov-nct02747485-2026-05-19`, retrieved 2026-10-26)
- Completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT02747485, source copy `cardio:ctgov-nct02747485-2026-05-19`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT02747485, source copy `cardio:ctgov-nct02747485-2026-05-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02747485-2026-05-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Impact of Diffuse Myocardial Fibrosis on the Ventricular Function in Regurgitant Left-Sided Valve Heart Diseases ( The DIFFUsE Study)
- Acronym: DIFFUsE
- Condition: Valve Heart Diseases
- Intervention (Device): Cardiac MRI
- Intervention (Biological): blood samples
- Intervention (Procedure): myocardial biopsy
- Intervention (Genetic): blood samples
- Lead sponsor: Assistance Publique Hopitaux De Marseille
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Assistance Publique Hopitaux De Marseille (`cardio:org-assistance-publique-hopitaux-de-marseille`)

## Provenance

Content hash: 05667286a57ccec271b0605f493195068d75c6ab9cf5613d6e5ee7bf97103af6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
